HCV

This Week in PLOS

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

The test detects and quantifies hepatitis C virus RNA and can be performed in approximately one hour. 

FIND will lead evaluation studies in Cameroon and Georgia between September 2018 and May 2019 to confirm the assay's diagnostic accuracy and commercial utility.

The firm's diagnostics division was up 4 percent. Molecular diagnostics grew 7 percent, cytology & perinatal was flat, and blood screening was down 2 percent.

Public sector programs in some low- and middle-income countries will obtain access to Hologic's Panther system through a single, all-inclusive pricing structure.

An RNA test in development that confirms whether a patient has HCV within 40 minutes could enable diagnosis and prescribing treatment during a single office visit.

The company said the disposal of these two businesses is part of a strategy to focus entirely on the molecular diagnostics market.

The firm showed 98 percent sensitivity and 100 percent specificity across all major HCV genotypes in a recent study.

The device is expected to be used with Genedrive's hepatitis C virus assay, which recently received CE-IVD marking.

The alliance follows a marketing deal signed with Sysmex Europe that covers Europe, the Middle East, and Africa.

Pages

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.